Due to the COVID-19 pandemic, more Medicare
patients with diabetes are currently eligible* for
coverage of the FreeStyle Libre 2 system
CGM = continuous glucose monitoring
Advanced Diabetes Supply
Better Living Now
Bridgewater Health Supplies
Byram Healthcare
CCS Medical
Diabetes Management & Supplies/AdaptHealth
Edgepark Medical Supplies
Edwards Health Care Services
J&B Medical Supply
Mini Pharmacy
Quest Health Solutions
Solara Medical Supplies/AdaptHealth
Total Medical Supply
United States Medical Supply
US HealthLink
Access a downloadable version of coverage and prescription information.
Use our Discussion Guide to help navigate the conversation with your doctor. The guide will help you understand personal diabetes management challenges and give you a list of questions to ask at your next visit.
1. Source: Patients must meet Medicare eligibility coverage criteria. Local Coverage Determination: Glucose Monitors LCD L33822 (February 2022)
Abbott provides this information as a courtesy, it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage or payment for our products or reimburse customers for claims that are denied by third party payors.
* Medicare coverage is available for the FreeStyle Libre 2 system if the FreeStyle Libre 2 reader is used to review glucose data on some days every month. Medicare and other third party payor criteria apply.
Abbott provides this information as a courtesy, it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage or payment for our products or reimburse customers for claims that are denied by third party payors.
* Participating pharmacies and durable medical equipment (DME) suppliers are subject to change without notice.
Learn how to set up your system today.
Abbott provides this information as a courtesy, it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage or payment for our products or reimburse customers for claims that are denied by third party payors.
Providers listed above include all DME suppliers who have contracted with ADC to acquire FreeStyle Libre family of products directly as of the “Last Updated” date who have represented to ADC they intend to recognize the flexibility provided by CMS.
FreeStyle Libre family of products may be available through other suppliers not listed who acquire these products indirectly.
This listing of participating suppliers are in alphabetical order and ADC has no preference on the supplier selected from the list. All DME suppliers who have contracted with ADC to acquire FreeStyle Libre family of products directly were eligible to be listed if they indicated they will supply CGM according to the CMS PHE guidelines1,2.
* Medicare patient eligibility status is compared to eligibility requirements prior to the conditional approval of the CMS interim final rule during the Public Health Emergency (CMS–5531–IFC) effective May 8, 2020 and recent approval of Proposed Local Coverage Determination (LCD): Glucose Monitors (L33822) effective July 18, 2021.
† Medicare coverage is available for the FreeStyle Libre 2 system if the FreeStyle Libre 2 reader is used to review glucose data on some days every month. Medicare and other third party payor criteria apply.
‡ FreeStyle Libre 14 day sensors communicate with the FreeStyle Libre 14 day readers that started them or the FreeStyle LibreLink app that started it. A sensor started by the FreeStyle Libre 14 day reader will also communicate with the FreeStyle LibreLink app once the FreeStyle LibreLink app is used to scan the sensor.
§ You cannot use both the FreeStyle Libre 2 reader and the FreeStyle Libre 2 app to scan the same FreeStyle Libre 2 sensor for glucose readings. If you start the Sensor with the App, then you cannot use the Reader to scan for glucose readings and if you start the Sensor with the Reader, then you cannot use the App to scan for glucose readings. Whichever device you start the Sensor with will receive alarms.
‖ Medicare coverage is available for FreeStyle Libre 14 day systems for cell phone use if FreeStyle LibreLink is used in conjunction with the FreeStyle Libre 14 day readers. Patients must meet Medicare eligibility coverage criteria LCD L33822 (February 2022). Local Coverage Article: Glucose Monitor Policy Article (A52464), February 2022.
¶ Data based on the number of patients assigned to each manufacturer based on last filled prescription in US Retail Pharmacy and DME.
References: 1. On May 8, 2020, CMS published a second interim final rule with comment, CMS-5531-IFC, that expanded the non-enforcement of clinical indications of coverage to therapeutic continuous glucose monitors (CGMs). This IFC also clarified that statutory reasonable and necessary statutory requirements are not being waived due to the PHE. https://www.govinfo.gov/content/pkg/FR-2020-05-08/pdf/2020-09608.pdf. 2. CMS Issues Interim Final Rules with Comment (CMS-1744-IFC & CMS-5531-IFC) – COVID-19 Public Health Emergency – Revised June 29, 2020, https://www.cgsmedicare.com/jc/pubs/news/2020/06/cope17942.html.
ADC-37051 v4.0 09/22
Important Safety Information
FreeStyle Libre 14 day system: Failure to use FreeStyle Libre 14 day system as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If readings do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety info.
FreeStyle Libre 2 and FreeStyle Libre 3 systems: Failure to use FreeStyle Libre 2 or FreeStyle Libre 3 systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose alarms and readings do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety info.
The product images are for illustrative purposes only.
The circular shape of the sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are the property of their respective owners.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without prior written authorization of Abbott Laboratories, except to identify the product or services of the company.
This website and the information contained herein is intended for use by residents of the United States.
ADC-29111 v17.0 02/23
The “Continue” link below will take you out of the Abbott Laboratories family of websites. Links which will take you out of Abbott Laboratories worldwide websites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the contents of any such site or any further links from such site. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott Laboratories.
Do you wish to continue and leave this site?
Disclaimer
FreeStylelibre.us is a product-specific website intended only for residents of the United States.
If you are a resident of another country, please visit our global directory to locate the appropriate site for your country.
ADC-29718 Ver 1.0 11/20